Abstract
The mechanism for ingenious tissue regeneration in mammals is roughly divided into two distinct systems. One is a system in which undifferentiated, vigorously proliferative stem cells assume the principal role in tissue regeneration. It operates to regenerate and repair tissues comprising differentiated cells that are no longer capable of proliferation, such as the hemopoietic tissue of bone marrow, nerve tissues and muscles. The other, termed the simple duplication system, is the regeneration for tissues whose cellular components are mature and differentiated, yet vitally capable of proliferation as seen in the regeneration of parenchymal organs such as the liver, kidney, and lung. Therefore, for organs with complicated multi-cellular architecture such as the liver, kidney, and lung, treatment of an injury by activation of simple duplication system will be a means of therapy in accordance with nature.
Keywords: HGF, Met, NK4, simple duplication, epithelial growth factor receptor, gene therapy, peripheral artery disease (PAD), c-Met, SHIP-2, plasmid DNA transfer, Phase III clinical trial, EPCs, Cbl, ROS, VSMC, CLI, Ang II, fibroblast growth factor, senescence, GTP binding rac1, Rutherford 5, ERK, Akt, ankle-brachial pressure index, QOL
Current Signal Transduction Therapy
Title: Introduction: Hepatocyte Growth Factor and Met Receptor, from Discovery to Therapeutic Implications
Volume: 6 Issue: 2
Author(s): Toshikazu Nakamura
Affiliation:
Keywords: HGF, Met, NK4, simple duplication, epithelial growth factor receptor, gene therapy, peripheral artery disease (PAD), c-Met, SHIP-2, plasmid DNA transfer, Phase III clinical trial, EPCs, Cbl, ROS, VSMC, CLI, Ang II, fibroblast growth factor, senescence, GTP binding rac1, Rutherford 5, ERK, Akt, ankle-brachial pressure index, QOL
Abstract: The mechanism for ingenious tissue regeneration in mammals is roughly divided into two distinct systems. One is a system in which undifferentiated, vigorously proliferative stem cells assume the principal role in tissue regeneration. It operates to regenerate and repair tissues comprising differentiated cells that are no longer capable of proliferation, such as the hemopoietic tissue of bone marrow, nerve tissues and muscles. The other, termed the simple duplication system, is the regeneration for tissues whose cellular components are mature and differentiated, yet vitally capable of proliferation as seen in the regeneration of parenchymal organs such as the liver, kidney, and lung. Therefore, for organs with complicated multi-cellular architecture such as the liver, kidney, and lung, treatment of an injury by activation of simple duplication system will be a means of therapy in accordance with nature.
Export Options
About this article
Cite this article as:
Nakamura Toshikazu, Introduction: Hepatocyte Growth Factor and Met Receptor, from Discovery to Therapeutic Implications, Current Signal Transduction Therapy 2011; 6 (2) . https://dx.doi.org/10.2174/157436211795659937
DOI https://dx.doi.org/10.2174/157436211795659937 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors
Current Cancer Drug Targets Cocaine Dependence and Stroke: Pathogenesis and Management
Current Neurovascular Research Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Pleiotropic Effects of Statin in Therapy in Heart Failure: A Review
Current Vascular Pharmacology G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Mild Improvement in Mitochondrial Function After a 3-Year Antiretroviral Treatment Interruption Despite Persistent Impairment of Mitochondrial DNA Content
Current HIV Research Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research Heart Failure Modulates the Muscle Reflex
Current Cardiology Reviews Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction
Current Pharmaceutical Design Endothelial Progenitors in Vascular Repair and Angiogenesis: How Many are Needed and What to do?
Cardiovascular & Hematological Disorders-Drug Targets Lifestyle Changes and Surgical Treatment for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets Autophagy and Mitochondria in Obesity and Type 2 Diabetes
Current Diabetes Reviews Erythropoietin: New Horizon in Cardiovascular Medicine
Recent Patents on Cardiovascular Drug Discovery Lipotoxicity Disrupts Erythrocyte Function: A Perspective
Cardiovascular & Hematological Disorders-Drug Targets